Pathophysiology of systemic sclerosis

被引:12
|
作者
Allanore, Yannick [1 ]
机构
[1] Univ Paris 05, Hop Cochin, Inst Cochin, INSERM,Rhumatol A,U1016, 27 Rue Faubourg St Jacques, F-75014 Paris, France
来源
M S-MEDECINE SCIENCES | 2016年 / 32卷 / 02期
关键词
PULMONARY ARTERIAL-HYPERTENSION; EXPERIMENTAL FIBROSIS; TOPOISOMERASE-I; DOWN-REGULATION; LUNG FIBROSIS; EXPRESSION; SKIN; AUTOIMMUNITY; ASSOCIATION; SCLERODERMA;
D O I
10.1051/medsci/20163202012
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Systemic sclerosis (SSc) is an orphan disease affecting the connective tissue. The cause of SSc remains unknown but is likely to involve environmental factors in a genetically primed individual with SSc belonging to the multigenic disorders. Pathogenesis is dominated by early microvascular changes targeting endothelial cells and with the release of several mediators promoting an inflammatory response and vascular remodelling. Several lines of evidence position autoimmunity as a key perpetuating event with activation of both innate and adaptive immunity and with the production of distinct autoantibodies. The cascade ultimates with the fibrosis defined by accumulation of extra-cellular matrix through an imbalance between synthesis and degradation of several components and mesenchymal cell activation and differentiation controlled by a large number of autocrine and paracrine factors.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 50 条
  • [41] Pathophysiology and treatment of systemic amyloidosis
    Julian D. Gillmore
    Philip N. Hawkins
    Nature Reviews Nephrology, 2013, 9 : 574 - 586
  • [42] PATHOPHYSIOLOGY AND THERAPY OF SYSTEMIC VASCULITIDES
    Ralli, Massimo
    Campo, Flaminia
    Angeletti, Diletta
    Minni, Antonio
    Artico, Marco
    Greco, Antonio
    Polimeni, Antonella
    de Vincentiis, Marco
    EXCLI JOURNAL, 2020, 19 : 817 - 854
  • [43] LEUKOTRIENES IN THE PATHOPHYSIOLOGY OF SYSTEMIC MASTOCYTOSIS
    HABERL, C
    DENZLINGER, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (13) : 463 - 463
  • [44] Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis
    Kazzam, E
    Caidahl, K
    Hedner, T
    Hedner, J
    Waldenström, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 (04) : 238 - 243
  • [45] Systemic sclerosis and multiple sclerosis
    Antonio Spadaro
    Felice Sensi
    Massimo Barrella
    A. Francia
    Journal of Neurology, 1999, 246 : 497 - 499
  • [46] The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapies
    Scaletti, Cristina
    Pratesi, Sara
    Randone, Silvia Bellando
    Di Pietro, Linda
    Campochiaro, Corrado
    Annunziato, Francesco
    Cerinic, Marco Matucci
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 219 (01):
  • [47] COMPLEX PATHOPHYSIOLOGY OF PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: MERITS AND DEMERITS OF AGGRESSIVE TREATMENT WITH PULMONARY VASODILATORS
    Kuwana, M.
    Tamura, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S137 - S138
  • [48] Systemic sclerosis and multiple sclerosis
    Spadaro, A
    Sensi, F
    Barrella, M
    Francia, A
    JOURNAL OF NEUROLOGY, 1999, 246 (06) : 497 - 499
  • [49] Systemic sclerosis
    Adler, Sabine
    NEPHROLOGE, 2021, 16 (06): : 336 - 342
  • [50] Systemic Sclerosis
    Schinke, Susanne
    Riemekasten, Gabriela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (08) : 550 - 556